Kawanishi, Japan

Teiji Kishimoto


Average Co-Inventor Count = 2.8

ph-index = 3

Forward Citations = 27(Granted Patents)


Location History:

  • Kawanishi, JA (1976 - 1978)
  • Kawanishi, JP (1980 - 1984)

Company Filing History:


Years Active: 1976-1984

Loading Chart...
7 patents (USPTO):Explore Patents

Title: Insights into the Innovative Mind of Teiji Kishimoto

Introduction

Teiji Kishimoto, an esteemed inventor based in Kawanishi, Japan, has made significant contributions to the field of pharmaceutical chemistry. With an impressive portfolio of seven patents, Kishimoto has demonstrated a keen ability to innovate within his area of expertise, particularly focusing on the development of compounds with relaxant activities on smooth muscles.

Latest Patents

Among his latest advancements, Kishimoto has developed various derivatives of 1,2,3,4-tetrahydroisoquinolines. These compounds are characterized by specific chemical structures wherein R1 and R2 can take on multiple forms such as hydrogen, lower alkyl, or aryl, with the potential for various substituents that enhance their pharmaceutical value. His work particularly emphasizes the smooth muscle relaxant activity of these compounds, showcasing their promise for therapeutic applications in medicine.

Career Highlights

Teiji Kishimoto is closely associated with Fujisawa Pharmaceutical Company, Ltd., a firm recognized for its commitment to developing innovative therapeutic solutions. His work has not only expanded the company's research horizons but has also contributed to advancements in drug formulation and delivery mechanisms. Kishimoto's drive for innovation is reflected in his patent records, which indicate a persistent quest to address healthcare challenges through scientific research.

Collaborations

Throughout his career, Kishimoto has had the opportunity to work alongside distinguished colleagues, including Hiromu Kochi and Yoshiyuki Kaneda. These collaborations have likely enriched his research output and fostered a collaborative spirit that underpins success in the field of pharmaceutical innovations.

Conclusion

In summary, Teiji Kishimoto's contributions to the pharmaceutical industry through his innovative patents and collaborative spirit mark him as a notable inventor in his field. His work not only showcases the potential of 1,2,3,4-tetrahydroisoquinoline derivatives in medicinal applications but also illustrates the importance of dedicated research in driving forward innovations for community health benefits.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…